Speaker
Biomarker Studies Asset Manager, Roche
Joseph Sutton, Biomarker Studies Asset Manager at Roche, is speaking at Novel CNS Biomarkers Summit Europe (London, United Kingdom, 30 Nov – 2 Dec 2026) in the session “Managing Multi-Site Biomarker Collection, Processing & Logistics – Ensuring Sample Integrity, Data Quality & Operational Success Across Global Trials”.
30 Nov – 2 Dec 2026London, United Kingdom
President & Chief Executive Officer, Progenra Inc
Vice President - Translational Biology, NRG Therapeutics
Neurological Disorders & Biofluid Specialist, Lundbeck
Founder & Chief Executive Officer, AltPep
Co-Founder & Chief Scientific Officer, Monument Therapeutics
Global Program Head Neurology, Duke University
This profile is built from conference programmes published on kongre.net. It has not been claimed or confirmed by Joseph Sutton, and it lists only the talks, sessions and presentations named in those programmes.
Is this you? Claim this profile — every request is read by a person before anything is linked.
To ask for a correction or for this profile to be removed, email [email protected].